Skip to main content

Anteris Technologies Global Corp.

corporate_fare Company Profile

Anteris Technologies Global Corp.

AVR·NASDAQ·Industrial Applications And Services·CIK 0002011514

Anteris Technologies Global Corp. is a structural heart company focused on cardiac care through science-driven advancements to restore heart valve patients to healthy function. Its lead product, the DurAVR® THV System, is designed to treat aortic stenosis, a potentially life-threatening narrowing of the aortic valve. The balloon-expandable DurAVR® THV is described as the first biomimetic valve, shaped to mimic the performance of a healthy human aortic valve and aiming to replicate normal aortic blood flow. The DurAVR® THV System consists of a single-piece, biomimetic valve made with the company's proprietary ADAPT® tissue-enhancing technology and deployed with its balloon-expandable ComASUR® Delivery System. ADAPT® is a proprietary anti-calcification tissue shaping technology designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. According to the cited publication by William Neethling et al., the patented ADAPT® tissue has been clinically demonstrated to be calcium free for up to 10 years post-procedure and has been distributed for use in over 55,000 patients globally in other indications. The ComASUR® Delivery System, developed in consultation with physicians, is designed to provide precise alignment with the heart's native commissures for accurate placement of the DurAVR® THV. As of December 2025, more than 130 patients have been implanted with the DurAVR® THV worldwide. Aortic stenosis is one of the most common and serious valvular heart diseases; it is fatal in approximately 50% of patients if left untreated after two years, and no pharmacotherapy is available to treat it.

Anteris Technologies Global Corp. (NASDAQ:AVR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 33 items for AVR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for AVR spans 10-Q, 4, S-3ASR, 424B3.

Recent high-impact activity:

  • Anteris Beats on Loss Per Share but Revenue Comes In Far Below Expectations
  • Anteris Posts $78.5M Nine-Month Loss; Material Weaknesses Still Unremediated
  • L1 Capital Adds $6.7M to Anteris Stake, Extending Reversal of Months-Long Selling
  • L1 Capital Reverses Course, Buys $3M of Anteris After Months of Selling
  • L1 Capital Extends Distribution Streak with Another $5.8M Sale of Anteris Technologies

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.91M
Net Income
-$94.14M
Diluted EPS
-$2.55
Op. Cash Flow
-$77.8M
Free Cash Flow
-$79.76M
Gross Profit
$1.34M
Operating Income
-$93.89M
Cash & Equivalents
$12.58M
Debt / Equity
0.00×
Net Margin
-49.21×
Shares Outstanding
41.58M sh
Source: 10-K · filed 2026-02-26 · accession 0001140361-26-006977

Short Interest & Short Volume

5.74 days to cover

FINRA reported short interest of 9,045,114 shares in AVR as of the October 30, 2026 settlement, a 14.0% increase from the prior period — about 5.7 days to cover at its recent average daily volume. On November 20, 2026, 57.7% of AVR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)9,045,114 shares as of October 30, 2026
Change vs prior period▲ 14.0%
Days to cover5.74 at avg daily volume of 1,576,788
Daily short volume (FINRA facilities)57.7% of 666,894 shares on November 20, 2026
5-day average short volume54.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for AVR, detected from its recent SEC filings · based on capital-structure filings through 2026-07-01.

1 recent capital raiseATM program1 shelf registration

$250 Million At-The-Market Offering Finalized · Significant Potential Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with A →
$5.09 +2.00% today
52-week range · as of 2026-11-10 $3.3 – $11.05
Market cap
$486.49M
Volume
1.5M (1.1× avg)
3-mo avg 1.4M
Live data · 2026-11-21 08:27 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AVR - Latest Insights

AVR
Nov 10, 2026, 5:20 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $5.90
Real-time Price: $5.09 info
Change: -$0.810 (-14%) info
Market Cap: $486.492M info
AVR
Nov 10, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.89
Real-time Price: $5.09 info
Change: -$0.800 (-14%) info
Market Cap: $486.492M info
AVR
Oct 06, 2026, 6:18 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $7.51
Real-time Price: $5.09 info
Change: -$2.42 (-32%) info
Market Cap: $486.492M info
AVR
Oct 01, 2026, 8:09 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $7.61
Real-time Price: $5.09 info
Change: -$2.52 (-33%) info
Market Cap: $486.492M info
AVR
Aug 12, 2026, 6:13 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $8.84
Real-time Price: $5.09 info
Change: -$3.75 (-42%) info
Market Cap: $486.492M info
AVR
Aug 11, 2026, 7:06 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $9.18
Real-time Price: $5.09 info
Change: -$4.09 (-45%) info
Market Cap: $486.492M info
AVR
Aug 11, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.00
Real-time Price: $5.09 info
Change: -$3.91 (-43%) info
Market Cap: $486.492M info
AVR
Aug 06, 2026, 6:48 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $8.20
Real-time Price: $5.09 info
Change: -$3.11 (-38%) info
Market Cap: $486.492M info
AVR
Jul 31, 2026, 6:25 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $7.91
Real-time Price: $5.09 info
Change: -$2.82 (-36%) info
Market Cap: $486.492M info
AVR
Jul 01, 2026, 5:12 PM EDT
Filing Type: S-3ASR
Importance Score:
7
Price at Filing: $9.95
Real-time Price: $5.09 info
Change: -$4.86 (-49%) info
Market Cap: $486.492M info
AVR
Jun 08, 2026, 6:06 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $9.59
Real-time Price: $5.09 info
Change: -$4.50 (-47%) info
Market Cap: $486.492M info
AVR
May 26, 2026, 4:45 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $9.08
Real-time Price: $5.09 info
Change: -$3.99 (-44%) info
Market Cap: $486.492M info
AVR
May 22, 2026, 5:23 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $9.16
Real-time Price: $5.09 info
Change: -$4.07 (-44%) info
Market Cap: $486.492M info
AVR
May 22, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.16
Real-time Price: $5.09 info
Change: -$4.07 (-44%) info
Market Cap: $486.492M info
AVR
May 22, 2026, 5:14 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $9.16
Real-time Price: $5.09 info
Change: -$4.07 (-44%) info
Market Cap: $486.492M info
AVR
May 12, 2026, 8:55 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.49
Real-time Price: $5.09 info
Change: -$1.40 (-22%) info
Market Cap: $486.492M info
AVR
May 12, 2026, 4:11 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $6.80
Real-time Price: $5.09 info
Change: -$1.71 (-25%) info
Market Cap: $486.492M info
AVR
May 12, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $6.57
Real-time Price: $5.09 info
Change: -$1.48 (-23%) info
Market Cap: $486.492M info
AVR
Apr 27, 2026, 6:03 AM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $5.50
Real-time Price: $5.09 info
Change: -$0.410 (-7%) info
Market Cap: $486.492M info
AVR
Apr 23, 2026, 5:13 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.53
Real-time Price: $5.09 info
Change: -$0.440 (-8%) info
Market Cap: $486.492M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets